Source: Indian Pharma Post

Piramal Critical Care: Piramal Critical Care announces US launch of Chlorpromazine Hydrochloride for Injection

The launch of Chlorpromazine Hydrochloride for Injection is the latest in a series of recent product launches from Piramal Critical Care

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Peter DeYoung's photo - CEO of Piramal Critical Care

CEO

Peter DeYoung

CEO Approval Rating

85/100